Page 264 - Read Online

Gacad et al. Vessel Plus 2019;3:28 I http://dx.doi.org/10.20517/2574-1209.2019.011 Page 7 of 10

DECLARATIONS
Authors’ contributions
Concept and design: Gacad V, Singh T, Motwani A, Samson R, Le Jemtel TH
Data acquisition: Gacad V, Singh T, Motwani A
Data analysis: Gacad V, Singh T, Motwani A
Manuscript preparation: Gacad V, Singh T, Motwani A
Critical revision and finalizing of the manuscript: Gacad V, Singh T, Motwani A, Samson R, Le Jemtel TH

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Koskinas KC, Windecker S, Räber L. Regression of coronary atherosclerosis: current evidence and future perspectives. Trends
Cardiovasc Med 2016;26:150-61.
2. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, et al. Effect of intensive compared with moderate lipid-lowering therapy on
progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-80.
3. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, et al. Effect of very high-intensity statin therapy on regression of coronary
atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556-65.
4. Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, et al. Effect of two intensive statin regimens on progression of
coronary disease. N Engl J Med 2011;365:2078-87.
5. VA Coronary Artery Bypass Surgery Cooperative Study Group. Eighteen-year follow-up in the veterans affairs cooperative study of
coronary artery bypass surgery for stable angina. Circulation 1992;86:121-30.
6. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, et al. 2012ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the
diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/
American Heart Association Task Force on, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association,
Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-164.
7. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, et al. Five-year outcomes after coronary stenting versus bypass surgery
for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J
Am Coll Cardiol 2005;46:575-81.
8. Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J
Med 2015;372:1204-12.
9. Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, et al. Randomized comparison of percutaneous coronary intervention with coronary
artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am
Coll Cardiol 2010;55:432-40.
10. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, et al. Strategies for multivessel revascularization in patients with diabetes.
N Engl J Med 2012;367:2375-84.
11. Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS